Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PSKH2 Activators

Protein serine kinase H2 (PSKH2) is a serine/threonine protein kinase that belongs to a larger family of kinases with diverse roles in cellular signaling. As an enzyme, PSKH2 catalyzes the transfer of a phosphate group from ATP to specific serine or threonine residues on target proteins. This post-translational modification can alter the activity, interactions, or localization of these proteins, thereby modulating various cellular processes.Although the full spectrum of PSKH2's biological functions is not completely understood, its kinase activity suggests it could play a role in regulating the cell cycle, DNA repair, apoptosis, and possibly other signaling pathways that are critical for cell proliferation and survival. Kinases like PSKH2 are often part of larger signaling cascades, where they can act as on/off switches for different signaling pathways in response to extracellular or intracellular stimuli.

The substrate specificity of PSKH2, as well as its particular interaction partners and regulatory mechanisms, are areas of ongoing research. Understanding these aspects is crucial for elucidating its function in physiological contexts, as well as in pathological conditions. Kinases often have multiple substrates and can be involved in cross-talk between signaling pathways, which adds complexity to their study.PSKH2's expression patterns, activity regulation by phosphorylation or other post-translational modifications, and its participation in protein complexes are all factors that could provide insight into its role in health and disease. As with many kinases, dysregulation of PSKH2's activity has the potential to contribute to disease states, including cancer, making it a potential target for intervention.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine, a broad-spectrum kinase inhibitor, could indirectly affect PSKH2 by altering the balance of kinase activity in the cell.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

As a protein kinase C inhibitor, Bisindolylmaleimide I might indirectly influence PSKH2 by modulating PKC-dependent signaling pathways.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein, a tyrosine kinase inhibitor, could indirectly affect PSKH2 activity by altering pathways that involve tyrosine phosphorylation.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin increases cAMP levels, potentially influencing PSKH2 indirectly if it's involved in cAMP-dependent signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, might affect PSKH2 activity indirectly by impacting PI3K/Akt signaling pathways.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126, an inhibitor of MEK1/2, could indirectly influence PSKH2 activity by affecting the ERK/MAPK signaling pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, may alter various cellular pathways, potentially influencing PSKH2 activity if it's involved in pathways regulated by mTOR.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059, an MEK inhibitor, might indirectly influence PSKH2 activity by affecting the ERK/MAPK signaling pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580, a p38 MAPK inhibitor, could indirectly affect PSKH2 activity by modulating MAPK-mediated signaling pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, could indirectly affect PSKH2 by altering PI3K/Akt signaling pathways.